BATF2-mediated control of astrocyte proliferation
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.110710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Rachel A Tinkey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Cleveland Clinic, Cleveland, Ohio, USA; School of Biomedical Sciences, Kent State University, Kent, Ohio, USA. Hauptthemen laut MEDLINE: Cell Proliferation, Basic-Leucine Zipper Transcription Factors, Astrocytes, Tumor Suppressor Proteins. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Multiple Sclerosis Society, National Institutes of Health.
Abstract (Originalsprache)
Astrocyte proliferation in the central nervous system is tightly controlled and is driven by the coordinated expression of regulatory proteins, including cyclins and cyclin-dependent kinases (CDKs), that dictate cell cycle progression. While most of the postnatal proliferation in the central nervous system occurs in well-defined stem cell niches, proliferation of differentiated glial cells can also be observed to maintain local populations during homeostasis and in response to inflammation. However, the transcriptional programs that regulate homeostatic proliferation of terminally differentiated astrocytes are not fully understood. Here, we identify a novel basic leucine zipper ATF-like transcription factor 2 (BATF2) as a prominent regulator of cell cycle genes in astrocytes. Specifically, loss of BATF2 resulted in increased expression of proliferation proteins, including Ki67 and phospho-histone H3. Further, chromatin immunoprecipitation sequencing revealed that BATF2 binds to regulatory regions of several cell cycle-related genes that encode CDK regulatory subunit 1B, CDK2, and cyclin D1 . Concomitantly, we found that deletion of BATF2 increased transcription of these target genes. In addition, we examined the relationship of BATF2 and cyclin D1 in patient-derived glioblastoma samples and found that elevated levels of BATF2 had a corresponding decrease in cyclin D1. Collectively, our study demonstrates that BATF2 participates in the control of astrocytic cell cycle gene expression and further highlights BATF2 as a suppressor of uncontrolled proliferation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences, Cleveland Clinic, Cleveland, Ohio, USA; School of Biomedical Sciences, Kent State University, Kent, Ohio, USA.
- Department of Neurosciences, Cleveland Clinic, Cleveland, Ohio, USA; College of Science, University of Notre Dame, South Bend, Indiana, USA.
- Department of Neurosciences, Cleveland Clinic, Cleveland, Ohio, USA; Department of Neurosciences, Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Neurosciences, Cleveland Clinic, Cleveland, Ohio, USA; School of Biomedical Sciences, Kent State University, Kent, Ohio, USA; Department of Neurosciences, Case Western Reserve University, Cleveland, Ohio,…
Förderung
- NINDS NIH HHS
- National Multiple Sclerosis Society
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Tinkey, R. A., Frostino, B. J., Habean, M. L., & Williams, J. L. (2025). BATF2-mediated control of astrocyte proliferation. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110710
Vancouver
Tinkey RA, Frostino BJ, Habean ML, Williams JL. BATF2-mediated control of astrocyte proliferation. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110710
BibTeX
@article{Tinkey2025,
author = {Tinkey, Rachel A and Frostino, Benjamin J and Habean, Maria L and Williams, Jessica L},
title = {BATF2-mediated control of astrocyte proliferation},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.110710}
}
EUVIMED